Please assess the completion status of the following clinical trial:

Trial Title: Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* All patients enrolled in the GIMEMA AML1310 study;~* Signed written informed consent according to ICH/EU/GCP and national local laws.~Exclusion Criteria:~* Patients not eligible for the GIMEMA AML1310 study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- All patients enrolled in the GIMEMA AML1310 study. (Type: None): * All patients enrolled in the GIMEMA AML1310 study;~* Signed written informed consent according to ICH/EU/GCP and national local laws.

Based on this trial design, predict the completion outcome and termination type (if applicable).